The intravenous infusion of ethanol serves as an antidote for methanol poisoning by leveraging a specific enzyme inhibition mechanism.
Methanol is toxic because it is metabolized by the enzyme alcohol dehydrogenase (ADH) into harmful substances like formaldehyde. Ethanol is also a substrate for ADH, but it has a higher affinity for the enzyme compared to methanol.
This process, where a molecule (ethanol) competes with the normal substrate (methanol) for the enzyme's active site, is known as competitive inhibition.
Therefore, the treatment mechanism relies fundamentally on competitive inhibition.
The kinetics of an enzyme in the presence (+I) or absence (-I) of a reversible inhibitor is described in the following graph.

If concentration of the reversible inhibitor in +I experiment was equal to $3.0 \times 10^{-3}$ M, then the dissociation constant for the enzyme-inhibitor complex is